Search results
4 paź 2013 · Blood samples were collected before and through 24 hours post-DMAA ingestion and analyzed for plasma DMAA concentration using high-performance liquid chromatography–mass spectrometry. Resting heart rate, blood pressure, and body temperature was also measured.
Before and after the intervention, resting blood pressure and heart rate were measured, and blood samples were collected for determination of complete blood count, metabolic panel and lipid panel.
Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the ...
3 lip 2023 · On top of that, after the regulating agencies ban a certain dangerous substance, mainstream sellers switch to others, and in the case of 1,3-DMAA, some of the substances that came after were 1,3-dimethylbutylamine DMBA and octodrine/2-amino-6-methylheptane (DMHA) .
Dimethylamylamine is a drug made synthetically in a laboratory. It was originally used as a nasal decongestant. Today, dimethylamylamine is sold as a dietary supplement used for attention deficit-hyperactive disorder (ADHD), weight loss, improving athletic performance, and body building.
19 lut 2013 · Data are specific to a sample of healthy, young men consuming daily dosage of caffeine (250 mg) and DMAA (50 mg) that are considered moderate and recommended. With the above understanding, it is possible that DMAA alone and in combination with caffeine may impact certain cardiorespiratory variables.
Caffeine and 1,3-dimethylamylamine (DMAA) are widely used alone and in combination with dietary supplements. No investigation has determined the safety profile of chronic intake of caffeine or DMAA, alone or in combination, within the same study design. A total of 50 young and healthy men completed 12 weeks of.
